Symmetry Surgical Inc. Completes Acquisition of The O.R. Company
Symmetry Surgical Inc. Completes Acquisition of The O.R. Company
Due to the COVID-19 virus most events have been cancelled or postponed.
Symmetry Surgical Inc. Completes Acquisition of The O.R. Company
Patented technology ensures a sharp Kerrison tip every time; Now available with hinge design for easy cleaning, inspection and lubrication
Symmetry Surgical, Inc., a leader in surgical instrumentation and solutions for all specialties and sites of care, is showcasing its latest cranial retraction innovation in the Greenberg® retractor product line, Greenberg® Simplicity, at the 2019 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting.
Symmetry Surgical, Inc., a leader in surgical instrumentation and solutions for all specialties and sites of care, unveiled an expanded Energy Solution consisting of the Olsen® product line and recently acquired Bovie® electrosurgery portfolio at the 56th AORN Global Surgical Conference & Expo.
Symmetry Surgical, Inc., a leader in surgical instrumentation and solutions across all surgical specialties and sites of care, will showcase new portfolio additions, including Reddick® Cholangiogram Catheters, Bovie® electrosurgery products and Symmetry VersaGrip® ergonomic modular instruments, at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting.
RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Symmetry Surgical Inc.® (“Symmetry” or the “Company”), completed its previously announced acquisition of the electrosurgical business of Bovie Medical (“Bovie” or the “Business”), inclusive of the Bovie® brand.
On July 9, 2018, Symmetry Surgical Inc. announced plans to acquire Bovie Medical’s electrosurgical business, including the Bovie® trademarks. The transaction is expected to close in the third quarter of 2018, subject to customary closing conditions. Once the transaction closes, Symmetry will become your exclusive source of Bovie® brand electrosurgical products and accessories.
RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has closed on its acquisition of Symmetry Surgical Inc. (“Symmetry” or the “Company”). Symmetry, based in Nashville, TN, is a leading marketer of reusable, reposable, and single-use surgical instrumentation and specialty devices. The definitive acquisition agreement was initially announced on May 2, 2016.
Symmetry Surgical Inc. (NASDAQ:SSRG) (“Symmetry” or the “Company”), today announced that it has entered into a definitive agreement to be acquired with an equity value of $140.3 million by an affiliate of RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry. Under the terms of the agreement, Symmetry shareholders will receive $13.10 in cash for each share of Symmetry common stock.
Symmetry Surgical Inc. (Nasdaq:SSRG) announced today that it has acquired the patent protected, ultra-low profile, soft-tissue retraction technology and related product portfolio, customer relationships and other assets from privately held Insightra® Medical for $400,000 and an undisclosed royalty.
Symmetry Surgical Inc. (Nasdaq: SSRG) announced today that Thomas J. Sullivan, President and Chief Executive Officer, and Scott D. Kunkel, Senior Vice President and Chief Financial Officer, are scheduled to present at the Stifel 2015 Healthcare Conference in New York City. This conference includes a formal presentation and will allow institutional investors to meet with Mr. Sullivan and Mr. Kunkel.
Symmetry Surgical Inc. announced today that it has acquired key assets of Vesocclude Medical, LLC (Vesocclude), including its product portfolio of titanium ligation clips and appliers, customer relationships and intellectual property for $4.0 million. The agreement also includes $2.2 million in potential payments based on the achievement of milestones related to new product commercialization, as well as distribution rights for the new products and additional rights for a future acquisition.
Symmetry Surgical Inc. (Nasdaq:SSRG) announced today that Thomas J. Sullivan, President and Chief Executive Officer, and Scott D. Kunkel, Senior Vice President and Chief Financial Officer, are scheduled to participate at two upcoming investor conferences. The first is the Sidoti Emerging Growth Conference in New York City. This conference includes a formal presentation and will allow institutional investors to meet with Mr. Sullivan and Mr. Kunkel.
Symmetry Surgical Inc. (Nasdaq:SSRG) announced today that Scott D. Kunkel, Senior Vice President and Chief Financial Officer, is scheduled to participate in the Avondale Partners 3rd Annual 1x1 Healthcare Conference in Boston, MA. Mr. Kunkel will be available for meetings with institutional investors at this conference.
Symmetry Surgical Inc. (Nasdaq:SSRG) announced today that Thomas J. Sullivan, President and Chief Executive Officer, is scheduled to present at the JMP Securities Life Sciences Conference in New York City. This conference includes a formal presentation and will allow institutional investors to meet with Mr. Sullivan.
Symmetry Surgical Inc. (Nasdaq:SSRG) announced today that Thomas J. Sullivan, President and Chief Executive Officer, is scheduled to participate in the UBS Global Healthcare Conference in New York City. Mr. Sullivan will be available for meetings with institutional investors at this conference.
Symmetry Surgical Inc. (Nasdaq:SSRG) announced today that Thomas J. Sullivan, President and Chief Executive Officer, is scheduled to participate at two upcoming investor conferences. The first is the BTIG Second Annual Snowbird Medical Technology, Diagnostics, and Healthcare IT Conference in Snowbird, UT. This conference will allow institutional investors to meet with the Company but does not include a formal presentation.
Symmetry Surgical Inc. (Nasdaq:SSRG) announced today an exclusive distribution agreement in the United States with neoSurgical Limited for its innovative neoClose® Trocar Port Closure System. Symmetry Surgical's sales representatives in the United States will begin selling the neoClose® System in the first quarter of 2015.
Symmetry Surgical Inc. (Nasdaq:SSRG) announced today that Company management will ring the Opening Bell at the Nasdaq MarketSite in Times Square, New York at 9:30 a.m. ET on Tuesday, December 23, 2014.
Symmetry Surgical Inc. (Nasdaq:SSRG) announced today that its separation from Symmetry Medical Inc. has been successfully completed. Symmetry Surgical will begin trading on the NASDAQ under the symbol "SSRG."
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, today held a special stockholder meeting at which stockholders approved the sale of Its OEM Solutions Business and separation of Symmetry Surgical Inc.
Symmetry Medical Inc. announced today that it has entered a definitive agreement to sell its OEM Solutions business to Tecomet and concurrently transfer to Symmetry Medical, Inc.’s shareholders ownership in a new company holding its Symmetry Surgical business. Tecomet, which is owned by Genstar Capital, is a contract manufacturing, engineering and metal fabrication technology company based in Wilmington, Massachusetts.
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that its subsidiary, Symmetry Surgical, is launching the Symmetry® Sharp Kerrison at the Association of periOperative Registered Nurses (AORN) Surgical Conference and Expo in Chicago, March 30 April 2, 2014.
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that its subsidiary, Symmetry Surgical, is launching the newest innovation in its industry-leading Bookwalter® portfolio, the Bookwalter® Femoral Elevator, at the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in New Orleans , March 11-15, 2014.
Symmetry Medical Inc. announced today that its subsidiary Symmetry Surgical, Inc. has completed an exclusive distribution agreement in Italy with Biocommerciale Srl. In this new partnership, Biocommerciale will distribute Symmetry Surgical's portfolio of surgical instruments, which includes leading brands and products formerly part of Codman surgical instruments, SSi and Olsen Medical.
Symmetry Medical Inc. announced today that its subsidiary, Symmetry Surgical, has entered into an exclusive distribution agreement with MTG Medical Technologies (MTG), subsidiary of Neuro-Competence, in Germany , Austria , Switzerland , Czech Republic , Hungary and Slovakia.
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that it received United States Food and Drug Administration ( FDA ) 510K clearance for its FLASH PAK® Evolution valve.
Symmetry Medical Inc. announced today that its subsidiary, Symmetry Surgical, has released new Neurosurgical Line Extensions. The Symmetry Micro Instruments, which were included as part of Symmetry Surgical's recent acquisition of the surgical instrument portfolio of Codman & Shurtleff, are single-shafted mechanical micro instruments specifically designed for neurosurgical procedures.
Symmetry Medical Inc. announced today its subsidiary, Symmetry Surgical, Inc. , has released new additions to its Quad-Lock™ Sterilization Container Portfolio. These additions include innovative Rongeur Instrument Holders that support the organization of many of Symmetry Surgical's newest products, including the patented RapidClean® Detachable Kerrison Rongeur and the Opti-Length® Extended Length Surgical Instruments for obese patient surgery.
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants and sterilization cases and trays, announced today it has launched the Staggs Uterine Compression Clamp through its hospital direct medical device segment, Symmetry Surgical, Inc.
Symmetry Medical Inc. announced today that its subsidiary, Symmetry Surgical, has completed an agreement with Japan Surgical Specialty (JSS) Corporation to distribute its leading medical device brands in Japan . The direct engagement of the Japanese market for Symmetry Surgical is in line with the global expansion of its recently expanded business, which includes leading brands from Symmetry Surgical, formerly Codman Surgical Instruments, & SSi.
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that its subsidiary Symmetry Surgical, Inc. has completed a distribution agreement in Australia and New Zealand with Device Technologies Australia, PTY Ltd. for the distribution of its direct surgical product portfolio.
Symmetry Medical Launches Enhancements to the BOOKWALTER(R) Surgical Retractor System